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Abstract
Background: Historically, specialist palliative care has been accessed by a greater proportion of people dying
with cancer compared to people with other life-limiting conditions. More recently, a variety of measures to
improve access to palliative care for people dying from non-cancer conditions have been implemented. There
are few rigorous population-based studies that document changes in palliative care service delivery relative to
the number of patients who could benefit from such services.
Method: A retrospective cohort study of the last year of life of persons with an underlying cause of death in
2009–10 from cancer, heart failure, renal failure, liver failure, chronic obstructive pulmonary disease, Alzheimer’s
disease, motor neurone disease, Parkinson’s disease, Huntington’s disease and/or HIV/AIDS. The proportion of
decedents receiving specialist palliative care was compared to a 2000–02 cohort. Logistic regression models were
used identify social and demographic factors associated with accessing specialist palliative care.
Results: There were 12,817 deaths included into the cohort; 7166 (56 %) from cancer, 527 (4 %) from both cancer
and non-cancer conditions and 5124 (40 %) from non-cancer conditions. Overall, 46.3 % of decedents received
community and/or hospital based specialist palliative care; a 3.5 % (95 % CI 2.3–4.7) increase on specialist palliative care
access reported ten years earlier. The majority (69 %; n = 4928) of decedents with cancer accessed palliative care during
the last year of life. Only 14 % (n = 729) of decedents with non-cancer conditions accessed specialist palliative care,
however, this represented a 6.1 % (95 % CI 4.9–7.3) increase on the specialist palliative care access reported for the
same decedent group ten years earlier. Compared to decedents with heart failure, increased odds of palliative care
access was observed for decedents with cancer (OR 10.5; 95 % CI 9.1–12.2), renal failure (OR 1.5; 95 % CI 1.3–1.9), liver
failure (OR 2.3; 95 % CI 1.7–3.3) or motor neurone disease (OR 4.5; 95 % CI 3.1–6.6). Living in major cities, being female,
having a partner and living in a private residence was associated with increased odds of access to specialist palliative care.
Conclusion: There is small but significant increase in access to specialist palliative care services in Western Australia,
specifically in patients dying with non-cancer conditions.
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Background
Specialist palliative care has been shown to improve
symptom management, reduce hospitalizations, allow
patients to be safely cared for at home and result in im-
proved patient and family satisfaction for both cancer
and non-cancer patients. Palliative care also lowers costs
by reducing acute care health service use [1]. One area
that remains a concern is the number of people with life
limiting non-cancer conditions who do not access spe-
cialist palliative care. Despite early calls to develop, fund
and evaluate appropriate cost effective services to meet
the needs of patients with advanced non-cancer diseases
[2, 3], there is little evidence to demonstrate significant
progress. A 2014 Spanish study that estimated the preva-
lence of patients in need of palliative care reported a ratio
of cancer to non-cancer patients as 1:7, although palliative
care service delivery was not measured [4]. A German
study from around the same time reported that inpatient
palliative care services were being delivered to an increasing
proportion of patients for non-cancer patients; an increase
from 3.5 to 8.1 % over a four year period [5]. Unfortunately
there are few rigorous population-based studies that docu-
mented changes in both community based and hospital
based palliative care service delivery relative to the number
of patients who could benefit from such services.
It is well established that people with non-cancer condi-
tions do not access specialist palliative care as readily. Defi-
nitions of palliative care rarely refer to specific diseases.
The World Health Organisation uses the terminology “life
threatening illness” in defining who should receive palliative
care [6]. Models of palliative care and gold standard frame-
works invariably propose the provision of services to people
with life limiting illness, regardless of diagnosis [7–9]. A
study using population-based estimates refined by expert
panel review argued that palliative care must be extended
to non-cancer conditions and that between 69 and 82 %
of people who die need palliative care [10]. Clinical evi-
dence demonstrates that there are commonalities in the
prevalence of problems across cancer and non-cancer
conditions [11, 12]. However, the illness trajectories of
non-cancer diseases may be longer and have unpredictable
fluctuations [13] both of which complicate the provision
of cost-effective specialist palliative care service. Other
complex factors such as patient and family awareness and
preparedness also impact the provision of palliative care
to people with non-cancer conditions [14].
Without significant progress towards the provision of
palliative care to people dying with non-cancer conditions,
we are not meeting the needs of those who could benefit
from palliative care under contemporary definitions. Data
provided at a population level greatly assists the delivery
of health services and can be used to promote greater ac-
cess to palliative care for people dying of non-cancer con-
ditions. This paper uses population-based Australian data
to examine trends in palliative care provision across a ten-
year period. The study investigates whether people dying
of non-cancer conditions are getting greater access to spe-
cialist palliative care, given current definitions and clinical
evidence to support the need for such care. It also ex-
plores other socio-demographic inequities in order to
highlight areas of under-developed specialist palliative
care service provision. There is ongoing concern that
older people [15] and people living in rural areas [16, 17]
may be missing out on specialist palliative care. Drawing
on an earlier Australian study which defined conditions
considered potentially amenable to palliative care [18], this
study traces specialist palliative care service use in the last
year of life by accessing linked mortality, hospital morbid-
ity and community nursing and medical services records.
Methods
Study design
This was a retrospective cohort study of the last year of life
of persons who had an underlying cause of death poten-
tially amenable to receiving palliative care. A de-identified
and linked extraction of death records, hospital morbidity
records and community-based care records of persons
who died in Western Australia (WA) from 1st January
2009 to 31st December 2010 was obtained from the Data
Linkage Branch at the WA Department of Health. The
data extraction also included geo-coded and type of resi-
dence information based on decedent’s residential address
at time of death and at each hospital admission. Ethical
approval to conduct this study was provided by Human
Research Ethics Committees at the WA Department of
Health and Curtin University.
Cohort selection
The cohort was identified by any mention of one or more
of the 10 disease conditions considered amenable for pal-
liative care as defined by Rosenwax et al. [18] coded any-
where in Part I (underlying cause of death) of the death
certificate. The 10 disease conditions were cancer, heart
failure, renal failure, liver failure, chronic obstructive pul-
monary disease, Alzheimer’s disease, motor neurone dis-
ease, Parkinson’s disease, Huntington’s disease and HIV/
AIDS. The International Classification of Disease (ICD)-
10-Australian Modification codes used to identify the dis-
ease conditions are supplied as Additional file 1: Table S1.
For decedents with more than one of the disease condi-
tions mentioned on Part 1 of the death certificate, a hier-
archical approach based on the death certification concept
of underlying cause was used to classify the principal dis-
ease condition [19]. For example, a decedent with liver
failure listed as the direct cause of death but who also had
carcinoma of pancreas recorded as the underlying ante-
cedent cause was assigned as having cancer as the princi-
pal disease condition amenable to palliative care. We note
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that using these classification rules meant that the princi-
pal disease condition did not always match the final single
underlying cause of death. For example, a decedent with
heart failure listed as a direct cause of death may have had
atrial fibrillation listed as the final underlying cause of
death but was still classified as heart failure being the prin-
cipal disease condition amenable to palliative care for the
purposes of this study. Information from Part II of the
death certificate (other significant conditions contributing
to death but not related to the condition causing it) was
not used to classify disease conditions amenable to pallia-
tive care here.
To directly compare findings here with those of a study
performed ten years earlier [3], the disease conditions con-
sidered amenable to palliative care in each decedent were
further grouped into being cancer conditions only, cancer
and non-cancer conditions or non-cancer conditions.
Defining specialist palliative care
Specialist palliative care was defined as receiving spe-
cific community-based or hospital-based palliative care.
Community-based care data was provided by Silver
Chain WA, a not-for-profit organisation that provides
over 90 % of all in-home health and care and 100 % of in-
home palliative care in WA [20]. Silver Chain community-
based palliative care is only provided with a referral from a
medical practitioner and includes at-home physical care
and practical support, symptom management (for ex-
ample pain, nausea), counselling and respite care. This
community-based palliative care may occur in private
residences or in non-hospital care facilities and was
mostly restricted to major urban areas and some coun-
try areas.
Hospital-based palliative care in WA is classified as care
in a hospital palliative care unit, in a designated palliative
care program or under the principal clinical management
of a palliative care physician or when the clinical intent of
care is palliation. Hospital-based palliative care was identi-
fied from hospital morbidity records where the episode of
care was coded as palliative and can be provided by most
major metropolitan, country hospitals and both private
and public hospices [21].
Social and demographic variables
Marital status at time of death was classified as partnered
(married or de-facto) or not/unknown. Geocoding of de-
cedents address at time of death was used to assign acces-
sibility to services categories that were based on the ARIA
+ index that takes into account road distance measure-
ments to the nearest Service Centres and population size
[22]. Similarly, geocoding was used to assign quintiles of
the Index of Relative Social Disadvantage [23]. Residences
at time of death were classified as private residence,
residential aged care facility, non-aged care facilities, or
other/unknown.
Statistical analysis
Data were structured so that every day of the last year of
life for each decedent was assigned to a care state. Care
states were classified as usual care, community-based non-
palliative care, community-based palliative care, hospital
non-palliative care and hospital palliative care. Decedents
who were residing in hospital were classified as receiving
hospital non-palliative care. Fishers’ exact tests were used
to assess equality of proportions including comparing pro-
portions of decedents receiving specialist palliative care
with those reported ten years earlier [3]. Logistic regres-
sion models were used to assess the strength of association
between accessing specialist palliative care and various
social, demographic and cause of death disease conditions.
Hosmer-Lemeshow goodness of fit tests were used to
evaluate model specification and plausible interaction terms
tested. Data manipulation and analysis were performed
using Stata v13 (College Station, TX).
Results
There were 23,852 non-trauma and non-obstetric related
deaths in Western Australia in 2009–2010 and of these,
12,817 (53.7 %) deaths met the criteria for inclusion into
the cohort of the 10 disease conditions considered as be-
ing amenable to receiving palliative care. There were
1,052 (8.2 %) decedents with more than one disease con-
ditions listed on Part 1 of the death certificate. Median
age at death was 78 years (Interquartile range 67–86
years) and ranged from 20 years to 107 years of age. The
mean age at death was slightly younger at 75.7 years
(Standard Deviation 13.5 years) indicating age was nega-
tively skewed. Socio-demographic characteristics of the
cohort are summarised in Table 1 by whether the princi-
pal cause of death conditions included cancers or not.
Sixty percent of the cohort had cancer mentioned on
Part 1 of the death certificate with a small proportion
(6.9 %) of these decedents also having other disease con-
ditions considered amenable to palliative care listed. In
general, decedents with cancer were younger, more likely
to have a partner and more likely to be living in a private
residence at time of death.
Use of hospital and community based palliative care in
last year of life
Overall, 46.3 % of decedents received at least one day in
the last year of life under community and/or hospital
based specialist palliative care (Table 2). This represents a
3.5 % (95 % CI 2.3–4.7; p-value <0.0001)) increase on spe-
cialist palliative care access reported ten years earlier [3].
Specialist palliative care in the last year of life was
accessed by 69 % of decedents with cancer only, with
Rosenwax et al. BMC Palliative Care  (2016) 15:46 Page 3 of 9
almost half (48 %) of cancer decedents accessing palliative
care via the community. There was no significant change in
the proportion of decedents with cancer who accessed spe-
cialist palliative care over the last ten years (p-value 0.182).
Around 20 % of decedents with cancer only accessed pallia-
tive care through a hospital only. For cancer decedents who
also had other cause of death conditions recorded on the
death certificate, access to specialist palliative care was re-
duced compared to those with cancer only.
Specialist palliative care was accessed by 14 % of dece-
dents with non-cancer conditions. While this is much
lower than that accessed by decedents with cancer, this
represents a 6.1 % (95 % CI 4.9 – 7.3; p-value <0.001) in-
crease on the specialist palliative care access reported for
the same decedent group ten years earlier [3]. The increase
in specialist palliative care observed for non-cancer condi-
tions occurred across both community based palliative
care and hospital based palliative care. The proportion of
decedents with non-cancer conditions who accessed com-
munity palliative care only increased from 3.1 to 4.7 %,
and for hospital based palliative care only increased from
3.9 to 8.0 % over ten years. Decedents with motor neurone
diseases and liver failure accessed specialist palliative care
most frequently out of the non-cancer conditions, followed
by renal failure. Those with liver failure tended to use
hospital-based palliative care whereas both hospital and
community palliative care was used by decedents with
motor neurone disease. The largest improvement in access
Table 1 Summary characteristics of the cohort at time of death by cause of death category (n = 12817)
Socio-demographic
variables
Cancer only Cancer + non cancer Non-cancer only All
n = 7166 n = 527 n = 5124 n = 12817
No. % No. % No. % No. %
Age at death (years)
< 60 1,262 17.6 72 13.7 322 6.3 1,656 12.9
60–69 1,527 21.3 83 15.7 402 7.8 2,012 15.7
70–79 2,007 28.0 167 31.7 1,035 20.2 3,209 25.0
80–89 1,904 26.6 175 33.2 2,138 41.7 4,217 32.9
90+ 466 6.5 30 5.7 1,227 23.9 1,723 13.4
Sex
Male 4,090 57.1 333 63.2 2,521 49.2 6,944 54.2
Female 3,076 42.9 194 36.8 2,603 50.8 5,873 45.8
Partnered at death
No 3,279 45.8 260 49.3 3,322 64.8 6,861 53.5
Yes 3,887 54.2 267 50.7 1,802 35.2 5,956 46.5
Accessibility of residence
Major cities 4,958 69.4 355 67.7 3,471 68.0 8,784 68.7
Inner regional 1,184 16.6 88 16.8 848 16.6 2,120 16.6
Outer regional 663 9.3 51 9.7 502 9.8 1,216 9.5
Remote 238 3.3 20 3.8 170 3.3 428 3.3
Very remote 106 1.5 10 1.9 117 2.3 233 1.8
IRSD of area of residence
Most disadvantage 1,464 20.5 132 25.2 1,192 23.3 2,788 21.8
More disadvantage 1,571 22.0 99 18.9 1,110 21.7 2,780 21.8
Average disadvantage 1,434 20.1 115 21.9 1,056 20.7 2,605 20.4
Less disadvantage 1,265 17.7 89 17.0 822 16.1 2,176 17.0
Least disadvantage 1,415 19.8 89 17.0 928 18.2 2,432 19.0
Residence type at death
Private 6,393 89.2 438 83.1 2,963 57.8 9,794 76.4
RACF 684 9.5 77 14.6 1,962 38.3 2,723 21.2
Other care facility 43 0.6 5 0.9 109 2.1 157 1.2
Unknown/NFA/other 46 0.6 7 1.3 90 1.8 143 1.1
RACF residential aged care facility, NFA no fixed address, IRSD Index of relative social disadvantage
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to specialist palliative care over the last ten years was ob-
served for liver failure and COPD followed by renal failure
and then heart failure. The numbers of decedents with
Huntington’s disease or HIV/AIDS were low and further
subgroup analyses were not performed to ensure decedent
confidentiality.
Number of days receiving specialist palliative care in the
last year of life
Of the 46 % of the cohort who did access specialist pallia-
tive care, the median number of days under specialist pal-
liative care was 25 days (IQR 8–75 days) but this varied
greatly by the principal cause of death condition. Decedents
with cancer and motor neurone disease received the most
specialist palliative care with a median of 30 (IQR 10–81))
and 34 (IQR 12–162) specialist palliative care days re-
spectively. The median number of days receiving spe-
cialist palliative care was lower for heart failure (5; IQR
2–15), renal failure (6; IQR 3–17), chronic obstructive
pulmonary disease (8; IQR 3–25), liver failure (7; IQR
4–18) and Alzheimer’s disease (5; IQR 3–11).
The temporal distribution of specialist palliative care ac-
cess days in the last year life was skewed towards the weeks
leading up to death. Over 60 % of total days of hospital-
based palliative care occurred in the four weeks before
death although this did vary by principal cause of death
condition. Hospital-based palliative care started a median
of 15 (IQR 6–44) days before death for decedents with can-
cer, 44 (IQR 8–149) days for motor neurone disease and 8
(IQR 4–22) days for decedents with liver failure. Decedents
with other cause of death conditions started hospital-based
palliative care a median of around 5–6 days before death.
Community-based palliative care tended to be accessed
earlier in the last year of life with a median starting date of
62 (IQR 26–137) days before death for cancer, 192 (IQR
19–365) days for Huntington’s disease and 86 (IQR 20–
253) days for motor neurone diseases. For the other condi-
tions, the median starting dates ranged from 6 (IQR 3–54)
days for Alzheimer’s disease up to 43 (IQR 15–138) days
for chronic obstructive pulmonary disease.
Factors associated with access to specialist palliative care
services
Ten years earlier it was reported that decedents with can-
cer who were not partnered, were living outside a major
city and were older than 85 years of age had reduced odds
of receiving specialist palliative care. Similar subgroup
analyses were performed here ten years later with in-
creased odds of specialist palliative care observed for
cancer decedents with a partner (OR 1.1; 95 % CI 1.0–
1.3; p-value 0.011), female cancer decedents (OR 1.2; 95
% CI 1.1–1.3; p-value 0.001), cancer decedents living in
a major city compared to very remote (OR 2.8; 95 % CI
1.8–43; p-value <0.001) or cancer decedents aged
Table 2 The number and proportion of cohort who accessed specialist palliative care in the last year of life (n = 12817)
Type of specialist palliative care received
Community only Hospital only Community and hospital
All No. n = 2270 n = 1986 n = 1676 Total specialist palliative care
Cause of death No. % No. % No. % No. % %Δa
Grouped
Cancer only 7166 1,907 26.6 1,484 20.7 1,537 21.4 4,928 68.8 +1.0
Cancer + non cancer 527 120 22.8 90 17.1 65 12.3 275 52.2 +4.0
Non cancer only 5124 243 4.7 412 8.0 74 1.4 729 14.2 +6.1*
Total 12817 2270 17.7 1986 15.5 1676 13.1 5,932 46.3 +3.5*
Principal
Cancer 7411 1,967 26.5 1,522 20.5 1,5651 21.1 5,054 68.2 +1.0
Heart failure 2019 94 4.7 148 7.3 23 1.1 265 13.1 +3.8*
Renal failure 1145 63 5.5 135 11.8 27 2.4 225 19.7 +8.1*
COPD 1094 86 7.9 84 7.7 26 2.4 196 17.9 +10.7*
Alzheimer’s 608 15 2.5 22 3.6 0 0.0 37 6.1 +2.7
Liver failure 206 15 7.3 41 19.9 12 5.8 68 33.0 +16.2*
Motor neurone 136 23 16.9 17 12.5 22 16.2 62 45.6 +10.3
Parkinson’s 181 <5 15 8.3 <5 21 11.6 +7.5
COPD chronic obstructive pulmonary disease. Cells with less than five decedents were listed as <5
*Statistically significant increases with p-value < 0.001
aPercentage change in the proportion of decedents in 2009/2010 who received specialist palliative care in the last year of life compared to that reported for
2000–2002 [3, 33]
% = row percentages. Due to low numbers, subgroup analyses are not shown for decedents with HIV/AIDS (n<5) or Huntington's disease (n=13)
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<60 years compared to 90 years (OR 1.8; 95 % CI 1.4–2.3;
p-value <0.001). It was also observed that cancer decedents
living in an aged care facility at time of death had much re-
duced odds of accessing specialist palliative care compared
to decedents living in a private residence (OR 0.2; 95 % CI
0.2–0.3; p-value <0.001). A similar subgroup analysis re-
stricted to non-cancer decedents observed that the only so-
cial and demographic variable associated with reduced
access to specialist palliative care was for those decedents
living in a care facility compared to a private residence (OR
0.4; 95 % CI 0.3–0.4; p-value <0.001).
However, a disadvantage of these subgroup analyses is
that comparisons of specialist palliative care use cannot be
made between subgroups and overall statistical power is
reduced. To overcome these limitations, two logistic re-
gression models that included all decedents were con-
structed; the first with all sociodemographic variables and
the second with all sociodemographic variables and the
underlying cause of death condition. In Adjusted Model 1,
all sociodemographic variables remained independently
significantly associated with access to specialist palliative
care when tested simultaneously using multivariate logis-
tic regression modelling (Table 3). Without taking any of
the causes of death into account, higher proportions of
decedents accessed specialist palliative care if they were
younger, male, had a partner, lived in more urban areas,
Table 3 The number, proportion and adjusted odds ratios of social and demographic characteristics associated with accessing
specialist palliative care (n = 12817)
Accessed any SPC Adjusted model 1a Adjusted model 2b
N % p-value OR 95 % CI p-value OR 95 % CI p-value
Age at death (years)
< 60 1,042 62.9 <0.001 3.3 2.8 − 3.9 <0.001 1.4 1.2 − 1.7 <0.001
60–69 1,207 60.0 2.8 2.4 − 3.3 <0.001 1.3 1.1 − 1.5 0.009
70–79 1,719 53.6 2.4 2.0 − 2.7 <0.001 1.4 1.2 − 1.6 <0.001
80–89 1,595 37.8 1.5 1.3 − 1.8 <0.001 1.1 1.0 − 1.3 0.095
90+ 369 21.4 1 ref − 1 ref −
Sex
Male 3,363 48.4 <0.001 1 ref − 1 ref −
Female 2,569 43.7 1.1 1.1 − 1.2 0.002 1.2 1.1 − 1.3 <0.001
Partner
No or unknown 2,646 38.6 <0.001 1 ref − 1 ref −
Yes 3,286 55.2 1.2 1.1 − 1.3 <0.001 1.2 1.1 − 1.3 0.001
Accessibility index
Major cities 4,234 48.2 <0.001 1 ref − 1 ref −
Inner regional 896 42.3 0.8 0.7 − 0.9 <0.001 0.8 0.7 − 0.9 <0.001
Outer regional 562 46.2 0.9 0.8 − 1.0 0.061 0.9 0.8 − 1.1 0.266
Remote 167 39.0 0.6 0.5 − 0.8 <0.001 0.6 0.5 − 0.7 <0.001
Very remote 65 27.9 0.4 0.3 − 0.6 <0.001 0.4 0.3 − 0.6 <0.001
IRSD of area of residence
1 (most disadvantaged) 1,217 43.7 <0.001 1 ref − 1 ref −
2 1,298 46.7 1.1 1.0 − 1.2 0.239 1.1 0.9 − 1.2 0.404
3 1,160 44.5 1.1 1.0 − 1.2 0.213 1.0 0.9 − 1.1 0.950
4 1,047 48.1 1.2 1.0 − 1.3 0.015 1.1 0.9 − 1.2 0.345
5 (least disadvantaged) 1,203 49.5 1.2 1.1 − 1.4 0.001 1.1 1.0 − 1.3 0.064
Residence at death
Private residence 5,472 55.9 <0.001 1 ref − 1 ref −
RACF 406 14.9 0.2 0.2 − 0.2 <0.001 0.3 0.2 − 0.3 <0.001
Non-aged care facility 25 15.9 0.2 0.1 − 0.3 <0.001 0.3 0.2 − 0.5 <0.001
Other/unknown 29 20.9 0.3 0.2 − 0.4 <0.001 0.4 0.2 − 0.6 <0.001
SPC specialist palliative care (hospital and/or community-based), IRSD Index of relative social disadvantage, RACF Residential aged care facility, OR Odds Ratio
aAdjusted model 1 included all social and demographic variables simultaneously; bAdjusted model 2 was identical to Adjusted Model 1 except it also included the
principal cause of death conditions (OR shown in results section text)
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lived in higher socioeconomic areas and lived in a private
residence at time of death.
When the underlying cause of death were also accounted
for, the relative impact of sociodemographic variables asso-
ciated with specialist palliative care was modified (Table 3;
Adjusted Model 2). Living in areas of lower socioeconomic
status was no longer associated with reduced access to spe-
cialist palliative care and the association of age at death
was not as marked. Decedents who were living in major
cities, were female, had a partner and were living in a pri-
vate residence at time of death still had increased odds of
access to specialist palliative care after adjusting for the
cause of death condition.
Using decedents with heart failure as the referent group
and adjusting for sociodemographic variables, the relative
odds of accessing specialist palliative care in the last year
of life was increased for decedents with cancer (OR 10.5;
95 % CI 9.1–12.2), renal failure (OR 1.5; 95 % CI 1.3–1.9),
liver failure (OR 2.3; 95 % CI 1.7–3.3) or motor neurone
disease (OR 4.5; 95 % CI 3.1–6.6). There was no signifi-
cant difference in the odds of access to any specialist pal-
liative care between decedents with heart failure and those
with chronic obstructive pulmonary disease, Alzheimer
disease, Parkinson’s disease, Huntington’s disease or HIV/
AIDS, however the small number of decedents in these
disease groups reduced the statistical power to detect any-
thing but very large differences.
Discussion
There has been a significant 3.5 % increase in access to
specialist palliative care services in the last year of life at a
population level over a ten year period. Most of this in-
crease was driven by increased uptake of palliative care
service by people dying of non-cancer related conditions,
particularly those with liver failure, COPD and renal fail-
ure. This is a positive sign that recommendations from
the 2005 WA Government Report and the subsequent
Palliative Care model of care endorsed in 2008 are having
an impact in the community [24, 25]. The 2005 Palliative
Care report highlighted the need to provide increased ser-
vices for life limiting illness, regardless of diagnosis, and
proposed working with existing support organizations of
conditions other than cancer. While the 6.5 % increase in
people with non-cancer conditions receiving specialist pal-
liative care is encouraging, we must still question why so
few people with non-cancer conditions still do not access
specialist palliative care.
In our study, the largest proportion of specialist pallia-
tive care users in the non-cancer group died with motor
neurone disease or liver failure. It was not surprising that
decedents with motor neurone disease had increased ex-
posure to specialist palliative care with over 30 % receiving
care in the community. The progressive and ultimately
fatal trajectory in most people with motor neurone disease
makes referral to specialist palliative care a more obvious
decision for clinicians. In addition, the not-for profit
Motor Neurone Disease Association has been providing
palliative care information and care support services to
patients and their families since 1983 [26].
In contrast to patients with motor neurone disease,
more decedents with liver failure received specialist pallia-
tive care in hospital rather than the community. This is
likely a reflection of the end-stage liver disease complexity,
comorbidity and difficulties with managing symptoms,
such as severe ascites, encephalopathy and variceal bleed-
ing, in the community. In addition, there is the uncertain
experience of waiting for a liver transplant, the only exist-
ing cure which is ultimately only available to a minority of
patients [27].
The proportion of decedents with other non-cancer con-
ditions considered amenable to palliative care who received
specialist palliative care in the last year of life was relatively
lower. Less than 20 % of decedents with the more common
life limiting conditions of heart failure, renal failure and
chronic pulmonary respiratory disease accessed specialist
palliative care in the last year of life - and this care was
accessed in the final few weeks. The reasons for the late ac-
cess to specialist palliative care is likely to be multifactorial
and condition specific although it has been observed that,
in general, patients with organ failure tend to have less un-
derstanding of the disease trajectory compared to patients
with cancer [14]. Similar patterns of palliative care in non-
cancer conditions are also reported elsewhere with 19 % of
heart failure patients accessing palliative care in a US set-
ting and the median time for first palliative care consult-
ation occurring only 21 days before death [28]. Reported
barriers to accessing palliative care in heart failure include
lack of patient awareness of the life-limiting or progressive
nature of their condition, a fear of hospice care not provid-
ing sufficient symptom relief [29], uncertain prognosis and
disease trajectory [30]. Given the high one year mortality
rate for heart failure it has been suggested that end of life
preparedness planning should be offered as early as time of
diagnosis [31].
Western Australia is the largest state in Australia with a
land area of 2.5 million km2 (larger than Western Europe),
mostly sparsely populated except for the south west cor-
ner which includes the capital city, Perth. We observed re-
duced access to specialist palliative care for decedents
living in inner regional and remote areas relative to those
living in the major cities, as was observed ten years earlier.
However, it does appear that decedents living in outer re-
gional areas now have similar access to specialist palliative
care as major urban areas. These finding are encouraging
and support a recent report on palliative care services in
rural areas of Western Australia that documented the es-
tablishment of regional palliative care teams, increased
education to palliative care providers, inclusion of social
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workers into palliative care teams and visiting palliative
care specialist services [32].
We noted that specialist palliative care was accessed
more often by younger decedents and decedents with
partners, regardless of the disease condition. We ques-
tion whether this is a reflection of societal perceptions
that the elderly are less needy in requiring end of life
care or whether coming to terms with and dealing with
imminent death is less burdensome as one ages? The in-
creased uptake of specialist palliative care in decedents
with partners at the time of death highlights the role
that the palliative care team plays in supporting carers
as well as the dying patient and is likely reflecting an in-
crease in advocacy by carers on behalf of their patients
in accessing palliative care.
While this study had the advantage of being large and
population based it did have several important limita-
tions. Firstly, we had little information on the severity of
the disease condition assigned as being amenable to pal-
liative care or whether the death was truly expected or
not. Thus it may not have always been clinically appro-
priate for the decedent to be referred to palliative care.
Secondly, we did not have data to estimate how much of
normal care provided by residential aged care facilities
could be classified as being palliative in nature, and thus,
we may be underestimating the level of palliative care
being delivered in these facilities. And lastly, we are also
likely to be underestimating the access to specialist pal-
liative care in rural areas because we relied on commu-
nity based palliative care data from a single provider that
is focused in urban areas. Measurement of improve-
ments in access for patients living in rural and remote
areas will require additional data to be conclusive. We
also acknowledge that life limiting conditions that may
benefit palliative care are likely to change over time, for
example, HIV/AIDS. These temporal changes need to be
considered when interpreting findings.
Conclusion
Encouraging findings are reported for improving pal-
liative care access in rural and remote areas. Import-
antly, we have also shown a small but significant
increase in access to specialist palliative care services
in Western Australia, specifically in patients dying with
non-cancer conditions. However, while palliative care
peak bodies continue to espouse that palliative care
should be available to all who need it regardless of
diagnosis, further work is needed. In particular, methods
to evaluate improvements such as we have presented here
are essential to document progress and are a first step in
providing much needed evidence to support changes in
funding and clinical practice to support palliative care
for all.
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